e-Article
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer
Document Type
Article
Author
Engstrom, L.D.; Aranda, R.; Waters, L.; Moya, K.; Bowcut, V.; Vegar, L.; Trinh, D.; Hebbert, A.; Smith, C.R.; Kulyk, S.; Lawson, J.D.; Hallin, J.; Vanderpool, D.; Briere, D.M.; Blaj, A.; Marx, M.A.; Christensen, J.G.; Shazer, R.; Olson, P.; He, L.; Hover, L.D.; Fernandez-Banet, J.; Rodon, J.; Offin, M.; Arbour, K.C.; Johnson, M.L.; Kwiatkowski, D.J.; Jänne, P.A.; Haddox, C.L.; Papadopoulos, K.P.; Henry, J.T.; Leventakos, K.
Source
In: Cancer Discovery . (Cancer Discovery, 1 November 2023, 13(11):2412-2431)
Subject
Language
English
ISSN
21598290
21598274
21598274